Good Clinical Practices and FDA Inspections Patricia Holobaugh Chief, Bioresearch Monitoring Branch Division of Inspections and Surveillance Office of.
Investigational New Drug (IND) Orientation Responsibilities of IND Sponsor-Investigators MICHR IND/IDE Assistance Program (MIAP)
